MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 37 filers reported holding MINERVA NEUROSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $836,000 | -5.5% | 480,629 | +26.0% | 0.08% | -15.0% |
| Q2 2021 | $885,000 | +128.7% | 381,488 | +187.5% | 0.10% | +56.2% |
| Q1 2021 | $387,000 | +42.8% | 132,670 | +14.4% | 0.06% | +45.5% |
| Q4 2020 | $271,000 | +344.3% | 116,010 | +1050.8% | 0.04% | +193.3% |
| Q1 2020 | $61,000 | -84.4% | 10,081 | -81.6% | 0.02% | -67.4% |
| Q4 2019 | $391,000 | +44.3% | 54,933 | +14.1% | 0.05% | +53.3% |
| Q2 2019 | $271,000 | -52.0% | 48,160 | -32.8% | 0.03% | -47.4% |
| Q1 2019 | $564,000 | +8.0% | 71,707 | -7.4% | 0.06% | -5.0% |
| Q4 2018 | $522,000 | -37.2% | 77,400 | +16.9% | 0.06% | +30.4% |
| Q3 2018 | $831,000 | +581.1% | 66,200 | +313.8% | 0.05% | +475.0% |
| Q3 2017 | $122,000 | -76.5% | 16,000 | -72.7% | 0.01% | -76.5% |
| Q2 2017 | $519,000 | +61.7% | 58,600 | +48.0% | 0.03% | +100.0% |
| Q1 2017 | $321,000 | – | 39,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 449,500 | $1,429,000 | 0.58% |
| Opaleye Management Inc. | 767,400 | $2,440,000 | 0.48% |
| FRAZIER MANAGEMENT LLC | 550,000 | $1,749,000 | 0.16% |
| FEDERATED HERMES, INC. | 9,610,200 | $30,560,000 | 0.07% |
| Artal Group S.A. | 760,000 | $2,417,000 | 0.06% |
| ARMISTICE CAPITAL, LLC | 500,000 | $1,590,000 | 0.06% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 63,114 | $201,000 | 0.04% |
| Cormorant Asset Management, LP | 238,817 | $759,000 | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 1,705,195 | $5,423,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 419,104 | $1,333,000 | 0.01% |